| Bioactivity | Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocorticotropic hormone (ACTH) and corticosterone levels in the plasma. Neuropeptide SF human play a physiologic role in the regulation of such circadian functions as the activity of motor centers and the HPA axis, through the release of CRH[1]. |
| CAS | 192387-39-6 |
| Sequence | Ser-Gln-Ala-Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 |
| Shortening | SQAFLFQPQRF-NH2 |
| Formula | C65H94N18O15 |
| Molar Mass | 1367.55 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jászberényi M, et al., The actions of neuropeptide SF on the hypothalamic-pituitary-adrenal axis and behavior in rats. Regul Pept. 2014 Jan 10;188:46-51. |
Neuropeptide SF (human)
CAS: 192387-39-6 F: C65H94N18O15 W: 1367.55
Neuropeptide SF human augments paraventricular corticotrophin-releasing hormone (CRH) release and increases adrenocortic
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.